Yesterday the innovative pharmaceutical industry and the Government of Alberta solidified a collaboration to ignite the life sciences sector in Alberta.
Quest Pharmatech's subsiduary Madenco Biosciences offer new line of "cosmeceuticals" to target needs of dermatologists and medi-spas.
OncoQuest Announces Enrollment of First Patient in Phase 1/2 Clinical Study Using Combination of Oregovomab with Checkpoint Inhibitor Nivolumab in Recurrent Ovarian Cancer
On March 16, 2017, Finance Minister Joe Ceci tabled the government's 2017 budget, which included tax credits to benefit the province's high-tech sector.
KMT Hepatech Inc. to offer freshly isolated or cryopreserved hyman hepatocytes to pharma, biotech, and other clients
The Canada-Alberta Job Grant (CAJG) is a funding program where employers and government share the cost of training new and existing employees to increase their knowledge and skills to meet the needs of Alberta’s changing economy.
Aquila Diagnostics is pleased to announce that has it been selected to present at the third annual Venture Summit West in Mountain View California on February 28-March 1.
The Alberta Diabetes Institute at the University of Alberta is pleased to announce a collaboration with Janssen Pharmaceuticals and its parent company Johnson & Johnson to advance early-stage technologies related to Type I and Type II diabetes.
Three organizations partner to establish $1.2M Alberta Transplant Innovation Fund. Through collaboration of researchers, clinicians, industry leaders, government and philanthropy, Funding research to improve care of transplant patients.